Literature DB >> 17875714

Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24.

Jay Harper1, Li Yan, Robyn M Loureiro, Iinmin Wu, Jianmin Fang, Patricia A D'Amore, Marsha A Moses.   

Abstract

Vascular endothelial growth factor (VEGF) is a potent stimulator of angiogenesis. Although many positive regulators of VEGF have been identified, relatively little is known regarding the negative regulation of VEGF expression. We identified a zinc finger transcription factor, ZNF24, that may repress VEGF transcription. An inverse correlation between expression of VEGF and ZNF24 was observed in a series of independent studies. ZNF24 was up-regulated in angiogenic tumor nodules where VEGF expression is significantly decreased compared with preangiogenic nodules. In human breast carcinoma cells cultured under normoxic conditions, ZNF24 levels were significantly up-regulated whereas VEGF levels were low. In contrast, VEGF was significantly increased in hypoxic cells whereas ZNF24 was down-regulated. The same inverse correlation between ZNF24 and VEGF was also observed in 70% of matched cDNA pairs of normal and malignant tissues from human colon and breast biopsies. Overexpression of ZNF24 resulted in a significant down-regulation of VEGF, whereas silencing of ZNF24 with small interfering RNA led to increased VEGF expression. Cotransfection of ZNF24 and a VEGF promoter luciferase reporter construct in MDA-MB-231 cells resulted in a significant decrease in VEGF promoter activity. Taken together, these data suggest that ZNF24 is involved in negative regulation of VEGF and may represent a novel repressor of VEGF transcription.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875714     DOI: 10.1158/0008-5472.CAN-07-1617

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Identification of novel non-invasive biomarkers of urinary chronic pelvic pain syndrome: findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.

Authors:  Adelle Dagher; Adam Curatolo; Monisha Sachdev; Alisa J Stephens; Chris Mullins; J Richard Landis; Adrie van Bokhoven; Andrew El-Hayek; John W Froehlich; Andrew C Briscoe; Roopali Roy; Jiang Yang; Michel A Pontari; David Zurakowski; Richard S Lee; Marsha A Moses
Journal:  BJU Int       Date:  2017-04-11       Impact factor: 5.588

2.  The dual role of TLR3 in metastatic cell line.

Authors:  Tanja Matijevic; Jasminka Pavelic
Journal:  Clin Exp Metastasis       Date:  2011-07-07       Impact factor: 5.150

3.  Transcriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo.

Authors:  Di Jia; Sean M Hasso; Joanne Chan; Domenic Filingeri; Patricia A D'Amore; Lori Rice; Christine Pampo; Dietmar W Siemann; David Zurakowski; Scott J Rodig; Marsha A Moses
Journal:  Blood       Date:  2012-12-03       Impact factor: 22.113

4.  Unbiased discovery of interactions at a control locus driving expression of the cancer-specific therapeutic and diagnostic target, mesothelin.

Authors:  Yunzhao R Ren; Raghothama Chaerkady; Shaohui Hu; Jun Wan; Jiang Qian; Heng Zhu; Akhilesh Pandey; Scott E Kern
Journal:  J Proteome Res       Date:  2012-10-12       Impact factor: 4.466

5.  The endogenous zinc finger transcription factor, ZNF24, modulates the angiogenic potential of human microvascular endothelial cells.

Authors:  Di Jia; Lan Huang; Joyce Bischoff; Marsha A Moses
Journal:  FASEB J       Date:  2014-12-30       Impact factor: 5.191

6.  A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells.

Authors:  Jing Huang; Peng Guo; Marsha A Moses
Journal:  J Vis Exp       Date:  2018-02-16       Impact factor: 1.355

7.  Endothelial cell migration and vascular endothelial growth factor expression are the result of loss of breast tissue polarity.

Authors:  Amy Chen; Ileana Cuevas; Paraic A Kenny; Hiroshi Miyake; Kimberley Mace; Cyrus Ghajar; Aaron Boudreau; Mina J Bissell; Mina Bissell; Nancy Boudreau
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

Review 8.  Systems biology of vascular endothelial growth factors.

Authors:  Feilim Mac Gabhann; Aleksander S Popel
Journal:  Microcirculation       Date:  2008-11       Impact factor: 2.628

9.  ZNF24 is upregulated in prostate cancer and facilitates the epithelial-to-mesenchymal transition through the regulation of Twist1.

Authors:  Xiangjiang Huang; Nanxin Liu; Xing Xiong
Journal:  Oncol Lett       Date:  2020-03-11       Impact factor: 2.967

10.  A transcript profiling approach reveals the zinc finger transcription factor ZNF191 is a pleiotropic factor.

Authors:  Jianzhong Li; Xia Chen; Xuelian Gong; Ying Liu; Hao Feng; Lei Qiu; Zhenlin Hu; Junping Zhang
Journal:  BMC Genomics       Date:  2009-05-22       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.